A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901).

Kadota T, Fujii R, Koyama S, Kotani D, Yoda Y, Fukutani M, Suzuki M, Wakabayashi M, Ikeno T, Sunakawa H, Nakamura Y, Kawazoe A, Irie T, Fuse N, Sato A, Yano T, Shitara K

Open source

DOI: 10.1007/s10120-025-01623-9
Published: 2025 Jul
Container: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10120-025-01623-9,
  title = {A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901).},
  author = {Kadota T and Fujii R and Koyama S and Kotani D and Yoda Y and Fukutani M and Suzuki M and Wakabayashi M and Ikeno T and Sunakawa H and Nakamura Y and Kawazoe A and Irie T and Fuse N and Sato A and Yano T and Shitara K},
  year = {2025},
  journal = {Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association},
  doi = {10.1007/s10120-025-01623-9},
  url = {https://doi.org/10.1007/s10120-025-01623-9}
}

RIS

TY  - JOUR
TI  - A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901).
AU  - Kadota T
AU  - Fujii R
AU  - Koyama S
AU  - Kotani D
AU  - Yoda Y
AU  - Fukutani M
AU  - Suzuki M
AU  - Wakabayashi M
AU  - Ikeno T
AU  - Sunakawa H
AU  - Nakamura Y
AU  - Kawazoe A
AU  - Irie T
AU  - Fuse N
AU  - Sato A
AU  - Yano T
AU  - Shitara K
PY  - 2025
JO  - Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
DO  - 10.1007/s10120-025-01623-9
UR  - https://doi.org/10.1007/s10120-025-01623-9
ER  -

APA

T, K., R, F., S, K., D, K., Y, Y., M, F., M, S., M, W., T, I., H, S., Y, N., A, K., T, I., N, F., A, S., T, Y., & K, S. (2025). A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901).. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. https://doi.org/10.1007/s10120-025-01623-9

Source records

pubmed · retrieved 2026-09-27T10:26:03.715Z